Kalshi· Financials

What will the FDA's decision be on Saroglitazar by Zydus Therapeutics in 2026?

Chance

77%

Buy Yes

80¢

pays $1 if it happens

Buy No

27¢

pays $1 if it doesn’t

Prices from Kalshi, updated 5 minutes ago. Ends Jan 1, 4:59 AM UTC.

Price over the last 2 weeks

Cost of a Yes share